Welcome to LookChem.com Sign In|Join Free

CAS

  • or

705262-64-2

Post Buying Request

705262-64-2 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

705262-64-2 Usage

Structure

Quinoxaline derivative with a bromo group and an ethylene glycol moiety

Usage

Building block for organic synthesis and medicinal chemistry, development of drugs and pharmaceuticals

Potential activities

Antiviral and antibacterial

Value

Can be used as a valuable intermediate in the synthesis of various biologically active compounds due to its diverse reactivity and biological properties.

Check Digit Verification of cas no

The CAS Registry Mumber 705262-64-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 7,0,5,2,6 and 2 respectively; the second part has 2 digits, 6 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 705262-64:
(8*7)+(7*0)+(6*5)+(5*2)+(4*6)+(3*2)+(2*6)+(1*4)=142
142 % 10 = 2
So 705262-64-2 is a valid CAS Registry Number.
InChI:InChI=1/C10H9BrN2O2/c11-7-1-2-8-9(5-7)13-10(6-12-8)15-4-3-14/h1-2,5-6,14H,3-4H2

705262-64-2SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name 2-(7-bromoquinoxalin-2-yl)oxyethanol

1.2 Other means of identification

Product number -
Other names 2-(7-bromo-quinoxalin-2-yloxy)-ethanol

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:705262-64-2 SDS

705262-64-2Downstream Products

705262-64-2Relevant articles and documents

FUSED PYRAZOLE DERIVATIVES AS TGF-BETA SIGNAL TRANSDUCTION INHIBITORS FOR THE TREATMENT OF FIBROSIS AND NEOPLASMS

-

Page/Page column 26-27, (2010/02/14)

The disclosed invention is directed to compounds of the formula: Formula (I) and methods of using these compounds.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 705262-64-2